アレルギー性鼻炎治療薬の世界市場予測:抗ヒスタミン剤、コルチコステロイド、免疫療法、ワクチン...市場調査レポートについてご紹介

【英文タイトル】Allergic Rhinitis Drugs Market Forecast 2015-2025 : Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Global
1.1 Global Allergic Rhinitis Drugs: Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. An Introduction To Allergic Rhinitis Drugs
2.1 The Pharmaceutical Industry: A Brief Introduction
2.1.1 Allergic Rhinitis Treatments – An Industry Overview
2.2 A Brief Overview Of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence Of Allergic Rhinitis
2.3.2 Pathophysiology Of Allergic Rhinitis: IgEs And Mast Cells
2.3.3 Symptoms Of Allergic Rhinitis
2.3.4 Classification Of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis And Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis Of Allergic Rhinitis
2.4 Treatment Of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- And Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy And Vaccines
2.5 Phases Of Clinical Trials
2.6 Scope Of This Report

3. The Global Allergic Rhinitis Drugs Market, 2015-2025
3.1 The Global Allergic Rhinitis Drugs Market: Market Overview
3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market
3.3 The Global Allergic Rhinitis Drugs Market In 2014
3.4 Leading Allergic Rhinitis Drugs, 2015
3.5 The Global Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
3.6 Allergic Rhinitis Drugs: Changing Market Shares By Sector 2015-2025

4. The Intranasal Antihistamines Market: Market Analysis And Forecast 2015-2025
4.1 Leading Products In The Intranasal Antihistamines Market, 2014
4.2 Intranasal Antihistamines: Market Trends And Developments, 2015
4.2.1 Azelastine Versus Olopatadine
4.2.2 Intranasal Combination Products
4.3 Intranasal Antihistamines: Market Forecast 2015-2025
4.3.1 Intranasal Antihistamines: Market Forecast by Volume, 2015-2025
4.3.2 Intranasal Antihistamines: Changing Market Shares By Leading Drugs 2015-2025
4.4 Leading Intranasal Antihistamines
4.5 Patanase (olopatadine) – Novartis
4.5.1 Patanase: Sales Forecast 2015-2025
4.6 Astepro (azelastine) – Meda Pharmaceuticals
4.6.1 Astepro: Sales Forecast 2015-2025
4.7 Astelin (azelastine) – Meda Pharmaceuticals
4.7.1 Astelin: Sales Forecast 2015-2025
4.8 Dymista (azelastine/fluticasone) – Meda Pharmaceuticals
4.8.1 Dymista: Sales Forecast 2015-2025
4.9 Generic Intranasal Azelastine
4.9.1 Generic Intranasal Azelastine: Sales Forecast By Value, 2015-2025
4.9.2 Generic Intranasal Azelastine: Sales Forecast By Volume, 2015-2025
4.10 Generic Intranasal Olopatadine
4.10.1 Generic Intranasal Olopatadine: Sales Forecast By Value, 2015-2025
4.10.2 Generic Intranasal Olopatadine: Sales Forecast By Volume, 2015-2025

5. Intranasal Corticosteroids Market: Market Analysis And Forecast 2015-2025
5.1 Leading Products In The Intranasal Corticosteroids Market, 2014
5.2 Intranasal Corticosteroids: Market Forecast 2015-2025
5.2.1 Intranasal Corticosteroids: Market Forecast by Volume, 2015-2025
5.2.2 Intranasal Corticosteroids: Changing Market Shares By Leading Drugs 2015-2025
5.3 Leading Intranasal Corticosteroids
5.4 Nasonex (mometasone) – Merck
5.4.1 Nasonex: Sales Forecast by Value, 2015-2025
5.4.2 Nasonex: Sales Forecast by Volume, 2015-2025
5.5 Avamys/Veramyst (fluticasone furoate) – GlaxoSmithKline
5.5.1 Avamys/Veramyst: Sales Forecast by Value, 2015-2025
5.5.2 Avamys/Veramyst: Sales Forecast by Volume, 2015-2025
5.6 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) – GlaxoSmithKline
5.6.1 Flixonase/Flonase/Flonase-OTC: Sales Forecast By Value, 2015-2025
5.6.2 Flixonase/Flonase/Flonase-OTC: Sales Forecast By Volume, 2015-2025
5.7 Rhinocort (budesonide) – AstraZeneca
5.7.1 Rhinocort: Sales Forecast by Value, 2015-2025
5.7.2 Rhinocort: Sales Forecast by Volume, 2015-2025
5.8 Omnaris (ciclesonide) – Dainippon Sumitomo/Takeda
5.8.1 Omnaris: Sales Forecast By Value, 2015-2025
5.8.2 Omnaris: Sales Forecast By Volume, 2015-2025
5.9 Nasacort/Nasacort-OTC (triamcinolone) – Sanofi
5.9.1 Nasacort/Nasacort-OTC: Sales Forecast By Value, 2015-2025
5.9.2 Nasacort: Sales Forecast By Volume, 2015-2025
5.10 Beconase/Beconase AQ (beclometasone) – GlaxoSmithKline/Omega Pharma
5.10.1 Beconase/Beconase AQ: Sales Forecast By Value, 2015-2025
5.10.2 Beconase/Beconase AQ: Sales Forecast by Volume, 2015-2025
5.11 Qnasl (beclometasone) – Teva
5.11.1 Qnasl: Sales Forecast by Value, 2015-2025
5.11.2 Qnasl: Sales Forecast by Volume, 2015-2025
5.12 Zetonna (ciclesonide) – Dainippon Sumitomo
5.12.1 Zetonna: Sales Forecast By Value, 2015-2025
5.12.2 Zetonna: Sales Forecast By Volume, 2015-2025
5.13 Generic Intranasal Corticosteroids
5.13.1 Generic Intranasal Beclometasone
5.13.1.1 Generic Intranasal Beclometasone: Sales Forecast By Value, 2015-2025
5.13.1.2 Generic Intranasal Beclometasone: Sales Forecast By Volume, 2015-2025
5.13.2 Generic Intranasal Budesonide
5.13.2.1 Generic Intranasal Budesonide: Sales Forecast By Value, 2015-2025
5.13.2.2 Generic Intranasal Budesonide: Sales Forecast By Volume, 2015-2025
5.13.3 Generic Intranasal Flunisolide
5.13.3.1 Generic Intranasal Flunisolide: Sales Forecast By Value, 2015-2025
5.13.3.2 Generic Intranasal Flunisolide: Sales Forecast By Volume, 2015-2025
5.13.4 Generic Intranasal Fluticasone
5.13.4.1 Generic Intranasal Fluticasone: Sales Forecast By Value, 2015-2025
5.13.4.2 Generic Intranasal Fluticasone: Sales Forecast By Volume, 2015-2025
5.13.5 Generic Intranasal Mometasone
5.13.5.1 Generic Intranasal Mometasone: Sales Forecast By Value, 2015-2025
5.13.5.2 Generic Intranasal Mometasone: Sales Forecast By Volume, 2015-2025
5.13.6 Generic Intranasal Triamcinolone
5.13.6.1 Generic Intranasal Triamcinolone: Sales Forecast By Value, 2015-2025
5.13.6.2 Generic Intranasal Triamcinolone: Sales Forecast By Volume, 2015-2025

6. Oral Antihistamines Market: Market Analysis And Forecast 2015-2025
6.1 Oral Antihistamines: Market Overview
6.1.1 Leading Products In The Oral Antihistamines Market, 2014
6.2 Oral Antihistamines: Market Trends And Developments, 2015
6.2.1 Patent Expiries And The Threat Of Generics
6.2.2 The Increasing Switch From Prescription To Over-The-Counter Sales
6.2.3 The Potential For Combination Therapy With Intranasal Corticosteroids
6.3 Oral Antihistamines: Market Forecast 2015-2025
6.3.1 Oral Antihistamines: Changing Market Shares By Leading Drugs 2015-2025
6.4 Leading Oral Antihistamines For The Treatment Of Allergic Rhinitis
6.5 Allegra/Allegra-D/Allegra OTC (fexofenadine) – Sanofi
6.5.1 Allegra/Allegra OTC: Historical Sales, 1995-2014
6.5.2 Allegra/Allegra OTC: Sales Forecast 2015-2025
6.6 Zyrtec/Zyrtec D (cetirizine) – Johnson & Johnson/ UCB/ GSK
6.6.1 Zyrtec/Zyrtec D: Sales Forecast 2015-2025
6.7 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co
6.7.1 Claritin/Claritin OTC: Sales Forecast 2015-2025
6.8 Xyzal (levocetirizine) – Sanofi/ UCB/ GSK
6.8.1 Xyzal: Sales Forecast 2015-2025
6.9 Allelock (olopatadine) – Kyowa Hakko Kirin
6.9.1 Allelock: Sales Forecast 2015-2025
6.10 Clarinex (desloratadine) – Merck & Co.
6.10.1 Clarinex: Sales Forecast 2015-2025
6.11 Ebastel (ebastine) – AstraZeneca/Takeda/Dainippon Sumitomo
6.11.1 Ebastel: Sales Forecast 2015-2025
6.12 Talion (bepotastine) – Mitsubishi Tanabe
6.12.1 Talion: Sales Forecast 2015-2025
6.13 Other Oral Antihistamines: Sales Forecast 2015-2025

7. Immunotherapy And Vaccines: Market Analysis And Forecast 2015-2025
7.1 Immunotherapy And Vaccines: Market Overview
7.1.1 Immunotherapy: Primed For Rapid Expansion
7.2 Leading Immunotherapy Products In The Allergic Rhinitis Market, 2014
7.3 Allergic Rhinitis Immunotherapy: Market Trends And Developments, 2015
7.3.1 Subcutaneous And Sublingual Immunotherapy
7.3.2 Expansion Into The US Market
7.3.3 Standardisation Of Immunotherapy Products
7.3.4 Immunotherapy As A Preventative Treatment
7.4 Allergic Rhinitis Immunotherapy: Market Forecast 2015-2025
7.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares By Leading Products 2015-2025
7.5 Immunotherapy Type – By Route Of Administration, 2014
7.6 Leading Immunotherapy Products For Allergic Rhinitis
7.7 Staloral (Grass pollen allergen extract) – Stallergenes
7.7.1 Staloral: Sales Forecast 2015-2025
7.8 Alutard SQ (Grass pollen allergen extract) – ALK-Abelló
7.8.1 Alutard SQ: Sales Forecast 2015-2025
7.9 Grazax/Grastek (Timothy grass pollen allergen extract) – ALK-Abelló/Merck
7.9.1 Grazax/Grastek: Sales Forecast 2015-2025
7.10 Oralair (Grass pollen allergen extract) – Stallergenes/Greer
7.10.1 Oralair: Sales Forecast 2015-2025
7.11 Ragwitek (Short ragweed pollen allergen extract) – Merck
7.11.1 Ragwitek: Sales Forecast 2015-2025
7.12 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2015-2025

8. Leading National Markets For Allergic Rhinitis Drugs, 2015-2025
8.1 The Allergic Rhinitis Drugs Market By Region
8.1.1 The Global Distribution Of Allergic Rhinitis Drugs In 2014
8.2 Leading National Markets: Forecast 2015-2025
8.2.1 Changing Market Shares By Region, 2015-2025
8.3 Regional Allergic Rhinitis Drugs Markets: Analysis And Forecasts, 2015-2025
8.4 United States: The Largest Allergic Rhinitis Drugs Market
8.4.1 US Allergic Rhinitis Drugs Market: Trends And Developments
8.4.1.1 The Trend Of Rx-to-OTC Switching
8.4.2 US Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5 EU5
8.5.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.1.1 EU5 Markets: Changing Market Shares By Country, 2015-2025
8.5.2 Germany
8.5.2.1 Germany: Reform Of AMNOG Pharmaceutical Rebate Law
8.5.2.2 German Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.3 UK
8.5.3.1 UK: Increasing Burden Of Allergy
8.5.3.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.4 France
8.5.4.1 France: Social Security Finance Act 2015
8.5.4.2 French Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.5 Italy
8.5.5.1 Italy: Government Cost Cutting Measures Impacting Market Growth
8.5.5.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.6 Spain
8.5.6.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.6 China
8.6.1 Air Pollution Associated With Increasing Prevalence
8.6.2 Expansion Of Healthcare Coverage And Reimbursement In China
8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.7 Japan
8.7.1 Cedar Reforestation And The Hay Fever Epidemic
8.7.2 Genetically Modified Rice As Immunotherapy
8.7.3 Effects Of The Rising Levels Of Generic Drug Penetration
8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.8 Russia
8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry?
8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.9 India
8.9.1 The Impact Of The Drug Prices Control Order On Indian Pharma
8.9.2 India’s Expansion Of Healthcare Provision
8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.10 Brazil
8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs
8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.11 Mexico
8.11.1 Are Multinationals Waking Up To Mexico’s Market Potential?
8.11.2 Mexican Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.12 Rest of the World
8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2015-2025

9. Leading Companies In The Allergic Rhinitis Drugs Market, 2015-2025
9.1 Allergic Rhinitis Drugs – An Evolving Market Space
9.1.1 Leading Companies In The Allergic Rhinitis Drugs Market, 2015
9.1.2 Allergic Rhinitis Drugs Market: Leading Companies Forecast 2015-2025
9.1.3 Allergic Rhinitis Drugs: Changing Market Shares By Leading Companies 2015-2025
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2015
9.2.2 ALK-Abelló: Recent Developments
9.2.2.1 Progress In The Approval Process For House Dust Mite (HDM) SLIT-Tablet
9.2.2.2 ALK Collaborates With EddingPharm To Boost China Sales
9.2.2.3 Jext Product Recall And The Subsequent Recovery
9.2.3 ALK-Abelló: Sales Forecast 2015-2025
9.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2015
9.3 GlaxoSmithKline (GSK)
9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2015
9.3.2 GlaxoSmithKline: Recent Developments
9.3.2.1 GSK Asset Swap with Novartis To Restructure Consumer Health
9.3.2.2 GSK Divestment of OTC Products
9.3.3 GlaxoSmithKline: Sales Forecast 2015-2025
9.3.4 GlaxoSmithKline: Allergic Rhinitis Drug Development Pipeline, 2015
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2015
9.4.2 Johnson & Johnson: Recent Developments
9.4.2.1 Launch of Zyrtec Dissolve Tabs
9.4.2.2 Manufacturing Recalls At McNeil Consumer Healthcare
9.4.3 Johnson & Johnson: Sales Forecast 2015-2025
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015
9.5.2 Kyowa Hakko Kirin: Sales Forecast 2015-2025
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2015
9.6.2 Merck: Recent Developments
9.6.2.1 Bayer Acquires Merck’s Consumer Health Business
9.6.2.2 FDA Rejects Singulair OTC Switch
9.6.3 Merck: Sales Forecast 2015-2025
9.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2015
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2015
9.7.2 Sanofi: Sales Forecast 2015-2025
9.8 Stallergenes
9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015
9.8.2 Stallergenes: Recent Developments
9.8.2.1 Stallergenes Acquires Argentinean Company Alergo Pharma
9.8.2.2 Greer Launches Oralair In The US
9.8.2.3 Proposed Merger With Greer
9.8.3 Stallergenes: Sales Forecast 2015-2025
9.8.4 Stallergenes: Allergic Rhinitis Drug Development Pipeline, 2015
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015
9.9.2 UCB: Sales Forecast 2015-2025
9.10 Other Leading Companies Within The Allergic Rhinitis Drugs Market

10. Allergic Rhinitis Drugs: Research And Development Pipeline, 2015-2025
10.1 Trends And Developments In The Allergic Rhinitis Pipeline
10.2 The R&D Pipeline For Oral Antihistamine, 2015
10.2.1 Talion (bepotastine) – Mitsubishi Tanabe
10.2.2 ZPL-3893787 (histamine H4R antagonist) – Ziarco Pharma
10.2.3 ZPL-868087 (oral histamine H3R antagonist) – Ziarco Pharma
10.3 The R&D Pipeline For Intranasal Corticosteroids, 2015
10.3.1 APC-3000 (HFA inhaled corticosteroid) – Adamis Pharmaceuticals
10.3.2 S0597 (topical glucocorticoid) – Sun Pharmaceuticals
10.3.3 TBS-6 – Trimel Pharmaceuticals
10.4 The R&D Pipeline For Immunotherapy In Allergic Rhinitis, 2015
10.4.1 Actair (house dust mite SLIT; STG320) – Stallergenes/Shionogi & Co
10.4.2 AllerT (subcutaneous birch pollen immunotherapy) – Anergis
10.4.3 Cat-SPIRE and other -SPIRE Therapies (synthetic peptide immunoregulatory epitopes) – Circassia Pharmaceuticals
10.4.4 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma
10.4.5 House Dust Mite SLIT-Tablet (MK-8237) – ALK-Abelló/Merck/Torii
10.4.6 Pollinex Quattro (subcutaneous immunotherapies) – Allergy Therapeutics
10.4.7 gp-ASIT+ (grass pollen allergen fragments) – Biotech Tools
10.4.8 Betula verrucosa (Bet v) 1 allergen – Stallergenes
10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs
10.5.1 eN-Lac (Lactobacillus paracasei GMNL-32) – GenMont Biotech
10.5.2 S-555739 (prostaglandin D2 receptor antagonist) – Shionogi
10.5.3 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) – Dainippon Sumitomo/ AstraZeneca
10.5.4 GSK2245035 (toll-like receptor 7 agonist) – GSK
10.5.5 HP-3060 (transdermal long-acting tape) – Hisamitsu
10.5.6 MRX-4 (anti-inflammatory agent) – Celsus Therapeutics
10.5.7 OC459 (OC000459) – Oxagen/ Atopix Therapeutics /Eleventa
10.5.8 ONO-4053 (prostaglandin D2 receptor antagonist) – Ono Pharmaceutical
10.5.9 WF10 (tetrachlorodecaoxygen chlorite matrix) – Nuvo Research
10.5.10 RPL554 (PDE-3/PDE-4 antagonist) – Verona Pharma
10.5.11 VTX-1463 (toll-like receptor 8 agonist) – VentiRx

11. Qualitative Analysis Of The Allergic Rhinitis Drugs Market, 2015-2025
11.1 Market Factors Influencing Allergic Rhinitis Drugs
11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2015-2025
11.2.1 Strengths
11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access
11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment
11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need
11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
11.2.2 Weaknesses
11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates
11.2.2.2 Increasing Penetration Of Generic Drug Products
11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
11.2.3 Opportunities
11.2.3.1 Growth In Emerging Markets Outstripping Established Markets
11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles
11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
11.2.4 Threats
11.2.4.1 Cost-Containment As A Growth Restraint
11.2.4.2 Rising Cost Of APIs And Manufacturing
11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue
11.3 Porter’s Five Force Analysis Of The Global Allergic Rhinitis Drugs Market, 2015-2025
11.3.1 Power of Buyers
11.3.2 Power Of Suppliers
11.3.3 Threat of Substitutes
11.3.4 Threat Of New Entrants
11.3.5 Rivalry Among Competitors

12. Expert Opinions From Our Primary Research
12.1 Interview with Tonya Winders, President and Chief Executive Officer, Allergy & Asthma Network
12.1.1 Allergy and Asthma Network And The Organisation’s Work In Allergic Rhinitis
12.1.2 Education Efforts Being Implement By Allergy & Asthma Network
12.1.3 Changing Conditions And The Impact On Allergic Rhinitis Prevalence And Severity
12.1.4 Climatic Changes And Its Impact On Allergic Rhinitis Incidence
12.1.5 Immunotherapy – Regulatory Hurdles And Its Adoption
12.1.6 Future Trends – Immunotherapies, Regulatory Approvals, Reimbursement
12.1.7 Allergy & Asthma Network’s Plans For The Future
12.2 Interview with Amena Warner, Nurse Advisor at Allergy UK And President, International Nurses Group In Immunodeficiencies
12.2.1 Allergy UK And The Organisation’s Work In Allergic Rhinitis
12.2.2 Allergy UK’s Patient Education Efforts
12.2.3 The Challenges Associated With The Treatment Options Available To Allergic Rhinitis Patients
12.2.4 Familial And Environmental Factors Influencing Allergic Rhinitis Prevalence
12.2.5 Immunotherapy And Its Impact On The Treatment Landscape For Allergic Rhinitis
12.2.6 Sublingual Immunotherapies And The Expanding Repertoire Of Allergic Rhinitis Treatments
12.2.7 Allergy UK’s Future Plans In Patient Education And Treatment Access
12.3 Interview with Dr Apelles Econs MRCS LRCP, Consultant – Allergy & Nutrition, Allergy Medical UK
12.3.1 On The Aetiology And Progression Of Allergy And Allergic Conditions
12.3.2 Factors Driving Allergic Rhinitis And The Familial Link
12.3.3 Developments And New Technologies In Diagnosing Allergies
12.3.4 Future Trends In Allergic Rhinitis Treatment And Allergy Medical UK’s Plans For The Future

13. Conclusions
13.1 Overview Of Current Market Conditions And Market Forecast, 2014-2025
13.2 Leading Sectors In The Allergic Rhinitis Drugs Market In 2014
13.3 Leading Regions In The Allergic Rhinitis Drugs Market In 2014
13.4 Leading Companies In The Allergic Rhinitis Drugs Market, 2014
13.5 What Does The Future Hold For Allergic Rhinitis Drugs?


【レポート販売概要】

■ タイトル:アレルギー性鼻炎治療薬の世界市場予測:抗ヒスタミン剤、コルチコステロイド、免疫療法、ワクチン
■ 英文:Allergic Rhinitis Drugs Market Forecast 2015-2025 : Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines
■ 発行日:2015年9月
■ 調査会社:visiongain
■ 商品コード:VGAIN5091105
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。